Product Information
MONTELUKAST SOD 5 MG TAB CHEW is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0704 per EA under NDC 57237021330. Its NADAC has been published 556 times since Feb 10, 2016.
FDA first approved this application on Aug 3, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237021330
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MONTELUKAST SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA202096FDA Approved
8/3/2012
TE Code
AB
On Market Since
8/3/2012
Pharmacological Classes
Price Statistics
The NADAC for MONTELUKAST SOD 5 MG TAB CHEW has been published 556 times since Feb 10, 2016, and over the history we have for it it has declined 71.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0704 per EA |
|---|---|
| All-time high | $0.2497 (Feb 10, 2016) |
| All-time low | $0.0600 (Nov 20, 2024) |
| 52-week high | $0.0742 |
| 52-week low | $0.0678 |
| Median price | $0.0921 |
| Average price | $0.1096 |
| Largest weekly change | -19.7% (Nov 23, 2016) |
| Weeks tracked | 556 |
| Tracking since | Feb 10, 2016 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Montelukast Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Leukotriene Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MONTELUKAST SOD 5 MG TAB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for MONTELUKAST SOD 5 MG TAB CHEW, manufactured by Rising Pharma Holdings Inc., is $0.0704 per EA (NDC 57237021330), effective Sep 30, 2026.
How has the price of MONTELUKAST SOD 5 MG TAB CHEW changed over time?
Over the history we have for it, the NADAC for MONTELUKAST SOD 5 MG TAB CHEW has declined 71.8%. It has been tracked across 556 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for MONTELUKAST SOD 5 MG TAB CHEW?
Since Feb 10, 2016, the NADAC for MONTELUKAST SOD 5 MG TAB CHEW has ranged from a low of $0.0600 (Nov 20, 2024) to a high of $0.2497 (Feb 10, 2016), with a median of $0.0921 per EA.
Are there cheaper alternatives to MONTELUKAST SOD 5 MG TAB CHEW?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MONTELUKAST SOD 5 MG TAB CHEW in a comparable dosage form, but none are currently priced below it.
Who manufactures MONTELUKAST SOD 5 MG TAB CHEW?
MONTELUKAST SOD 5 MG TAB CHEW (NDC 57237021330) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.